F8 (coagulation factor VIII)

2007-02-01  

Identity

HGNC
LOCATION
Xq28
LOCUSID
ALIAS
AHF,DXS1253E,F8B,F8C,FVIII,HEMA
FUSION GENES

Other Information

Locus ID:

NCBI: 2157
MIM: 300841
HGNC: 3546
Ensembl: ENSG00000185010

Variants:

dbSNP: 2157
ClinVar: 2157
TCGA: ENSG00000185010
COSMIC: F8

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000185010ENST00000330287P00451
ENSG00000185010ENST00000360256P00451
ENSG00000185010ENST00000423959B1B0G8
ENSG00000185010ENST00000453950B1B0G9
ENSG00000185010ENST00000644698A0A2R8Y707
ENSG00000185010ENST00000647125A0A2R8Y7J7

Expression (GTEx)

0
5
10
15
20

Pathways

PathwaySourceExternal ID
Complement and coagulation cascadesKEGGko04610
Complement and coagulation cascadesKEGGhsa04610
Metabolism of proteinsREACTOMER-HSA-392499
Post-translational protein modificationREACTOMER-HSA-597592
Asparagine N-linked glycosylationREACTOMER-HSA-446203
Transport to the Golgi and subsequent modificationREACTOMER-HSA-948021
ER to Golgi Anterograde TransportREACTOMER-HSA-199977
COPII (Coat Protein 2) Mediated Vesicle TransportREACTOMER-HSA-204005
HemostasisREACTOMER-HSA-109582
Platelet activation, signaling and aggregationREACTOMER-HSA-76002
Response to elevated platelet cytosolic Ca2+REACTOMER-HSA-76005
Platelet degranulationREACTOMER-HSA-114608
Formation of Fibrin Clot (Clotting Cascade)REACTOMER-HSA-140877
Intrinsic Pathway of Fibrin Clot FormationREACTOMER-HSA-140837
Common Pathway of Fibrin Clot FormationREACTOMER-HSA-140875
Vesicle-mediated transportREACTOMER-HSA-5653656
Membrane TraffickingREACTOMER-HSA-199991
Cargo concentration in the ERREACTOMER-HSA-5694530

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
379250342024The role of proteolytic cleavage at Arg(336) and Arg(372) of the A1 domain in factor VIIa/tissue factor-catalyzed reactions of B domain-deleted factor VIII.0
379623032024An intronic RNA element modulates Factor VIII exon-16 splicing.1
383174802024Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment.1
383201212024A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels.0
386311562024In-depth structure-function profiling of the complex formation between clotting factor VIII and heme.0
379250342024The role of proteolytic cleavage at Arg(336) and Arg(372) of the A1 domain in factor VIIa/tissue factor-catalyzed reactions of B domain-deleted factor VIII.0
379623032024An intronic RNA element modulates Factor VIII exon-16 splicing.1
383174802024Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment.1
383201212024A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels.0
386311562024In-depth structure-function profiling of the complex formation between clotting factor VIII and heme.0
359245812023Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association.1
362402942023Mechano-covalent protection of coagulation factor VIII by von Willebrand factor.1
363229042023Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential.0
377260332023Coagulation factor VIII regulates von Willebrand factor homeostasis invivo.1
359245812023Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association.1

Citation

Dessen P

F8 (coagulation factor VIII)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/45656